Trastuzumab is a monoclonal antibody used to treat breast cancer and stomach cancer that is HER2 receptor positive.
It is available in multiple forms, including as part of a treatment course, alone after treatment with multiple other therapies, or as a combination with chemotherapy drugs.
It is also used to treat high-risk cancer, metastatic cancer, and stomach adenocarcinoma.
Additionally, it is used to treat early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach.
Side effects may include fever, chills, nausea, vomiting, and diarrhea.
Herceptin is an approved treatment for early-stage breast cancer that is HER2+ and has spread into the lymph nodes, or is HER2-positive and has not spread into the lymph nodes. It is available in multiple forms, including as part of a treatment course, alone after treatment with multiple other therapies, or as a combination with chemotherapy drugs. Patients are selected for therapy based on an FDA-approved test for Herceptin, and should be aware of potential side effects and other potential side effects.
HER2+ Cancer Treatment Option | Herceptin® (trastuzumab)
Trastuzumab is an FDA-approved drug used to treat breast cancer that is HER2 positive, hormone receptor-negative or high-risk cancer, metastatic cancer, and stomach adenocarcinoma. It is available in three different forms, and is being studied in the treatment of other types of cancer. Clinical trials are currently accepting patients to check for Trastuzumab, and it is important to see a healthcare professional for more information about your specific medical condition and the use of this drug.
Trastuzumab - NCI - National Cancer Institute
Trastuzumab , sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.
Trastuzumab - Wikipedia
Trastuzumab is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach (gastro oesophageal junction).
Trastuzumab (Herceptin) | Cancer information | Cancer Research UK
Trastuzumab is used to treat certain types of breast cancer or stomach cancer , sometimes in combination with other cancer medicines.
trastuzumab is sometimes used when the cancer has spread to other parts of the body (metastatic).
Trastuzumab may also be used for purposes not listed in this medication guide
Trastuzumab Uses, Side Effects & Warnings - Drugs.com
Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. Brand Names Herceptin, Herceptin Hylecta, Herzuma, Kanjinti, Ontruzant, Perjeta-Herceptin,…
Trastuzumab: Uses, Interactions, Mechanism of Action - DrugBank
Trastuzumab is used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. As part of chemotherapy regimen for adjuvant treatment of lymph-node positive,…
Trastuzumab - Chemotherapy Drugs - Chemocare